Research progress on the application of organoids in genetic diseases of childhood

doi:10.11958/20231509

Abstract

Abstract:

Organoids are in vitro 3D tissue cultures that retain the characteristics of their source tissue and organs, and have been widely used in biomedical fields. Organoids have emerged as effective models for investigating diseases, contribute to further understanding of pathophysiology and molecular mechanisms of diseases, and provide technical support for personalized treatment of genetic diseases. This article specifically explores the application of organoid technology in childhood genetic diseases. It emphasizes the advantages and potential advancements of this technology in disease modeling, correction of genetic defects and personalized treatment, thereby serving as a valuable reference for future research endeavors.

Key words: organoids, microchip analytical procedures, genetic diseases, inborn, gene diting, drug evaluation, preclinical, drug screening assays

CLC Number:

R725

References 36

[1]	KOZLOWSKI M T, CROOK C J, KU H T. Towards organoid culture without Matrigel[J]. Commun Biol, 2021, 4(1):1387. doi:10.1038/s42003-021-02910-8.
[2]	ZHOU Z, CONG L, CONG X, et al. Patient-derived organoids in precision medicine:drug screening,organoid-on-a-chip and living organoid biobank[J]. Front Oncol, 2021, 11:762184. doi:10.3389/fonc.2021.762184.
[3]	GARRETA E, KAMM R D, CHUVA DE SOUSA LOPES S M, et al. Rethinking organoid technology through bioengineering[J]. Nat Mater, 2021, 20(2):145-155. doi:10.1038/s41563-020-00804-4.
[4]	SATO T, STANGE D E, FERRANTE M, et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium[J]. Gastroenterology, 2011, 141(5):1762-1772. doi:10.1053/j.gastro.2011.07.050.
[5]	ZHU L, FAN Y, HUANG X, et al. Patent bibliometric analysis for global trend of organoid technologies in the past decade[J]. iScience, 2022, 25(8):104728. doi:10.1016/j.isci.2022.104728.
[6]	CHO S W, KIM S, KIM J M, et al. Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease[J]. Nat Biotechnol, 2013, 31(3):230-232. doi:10.1038/nbt.2507.
[7]	DE POEL E, LEFFERTS J W, BEEKMAN J M. Intestinal organoids for Cystic Fibrosis research[J]. J Cyst Fibros, 2020, 19(Suppl 1):S60-S64. doi:10.1016/j.jcf.2019.11.002.
[8]	DEKKERS J F, WIEGERINCK C L, DE JONGE H R, et al. A functional CFTR assay using primary cystic fibrosis intestinal organoids[J]. Nat Med, 2013, 19(7):939-945. doi:10.1038/nm.3201.
[9]	BIJVELDS M, ROOS F, MEIJSEN K F, et al. Rescue of chloride and bicarbonate transport by elexacaftor-ivacaftor-tezacaftor in organoid-derived CF intestinal and cholangiocyte monolayers[J]. J Cyst Fibros, 2022, 21(3):537-543. doi:10.1016/j.jcf.2021.12.006.
[10]	RODENBURG L W, DELPIANO L, RAILEAN V, et al. Drug repurposing for cystic fibrosis: identification of drugs that induce CFTR-independent fluid secretion in nasal organoids[J]. Int J Mol Sci, 2022, 23(20):12657. doi:10.3390/ijms232012657.
[11]	HIRAI H, LIANG X, SUN Y, et al. The sodium/glucose cotransporters as potential therapeutic targets for CF lung diseases revealed by human lung organoid swelling assay[J]. Mol Ther Methods Clin Dev, 2022, 24:11-19. doi:10.1016/j.omtm.2021.11.008.
[12]	LANCASTER M A, RENNER M, MARTIN C A, et al. Cerebral organoids model human brain development and microcephaly[J]. Nature, 2013, 501(7467):373-379. doi:10.1038/nature12517.
[13]	DELL'AMICO C, ANGULO SALAVARRIA M M, TAKEO Y, et al. Microcephaly-associated protein WDR62 shuttles from the Golgi apparatus to the spindle poles in human neural progenitors[J]. Elife, 2023, 12:e81716. doi:10.7554/eLife.81716.
[14]	AN H L, KUO H C, TANG T K. Modeling human primary microcephaly with hiPSC-derived brain organoids carrying CPAP-E1235V disease-associated mutant protein[J]. Front Cell Dev Biol, 2022, 10:830432. doi:10.3389/fcell.2022.830432.
[15]	FAIR S R, SCHWIND W, JULIAN D L, et al. Cerebral organoids containing an AUTS2 missense variant model microcephaly[J]. Brain, 2023, 146(1):387-404. doi:10.1093/brain/awac244.
[16]	PENISSON M, JIN M, WANG S, et al. Lis1 mutation prevents basal radial glia-like cell production in the mouse[J]. Hum Mol Genet, 2022, 31(6):942-957. doi:10.1093/hmg/ddab295.
[17]	ZHANG W, MA L, YANG M, et al. Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly/autism phenotypes[J]. Genes Dev, 2020, 34(7/8):580-597. doi:10.1101/gad.332494.119.
[18]	BIGORGNE A E, FARIN H F, LEMOINE R, et al. TTC7A mutations disrupt intestinal epithelial apicobasal polarity[J]. J Clin Invest, 2014, 124(1):328-337. doi:10.1172/JCI71471.
[19]	DUCLAUX-LORAS R, LEBRETON C, BERTHELET J, et al. UNC45A deficiency causes microvillus inclusion disease-like phenotype by impairing myosin VB-dependent apical trafficking[J]. J Clin Invest, 2022, 132(10):e154997. doi:10.1172/JCI154997.
[20]	GUAN Y, XU D, GARFIN P M, et al. Human hepatic organoids for the analysis of human genetic diseases[J]. JCI Insight, 2017, 2(17):e94954. doi:10.1172/jci.insight.94954.
[21]	SCHWANK G, KOO B K, SASSELLI V, et al. Functional repair of CFTR by CRISPR/Cas9 in intestinal stem cell organoids of cystic fibrosis patients[J]. Cell Stem Cell, 2013, 13(6):653-658. doi:10.1016/j.stem.2013.11.002.
[22]	GEURTS M H, DE POEL E, AMATNGALIM G D, et al. CRISPR-based adenine editors correct nonsense mutations in a cystic fibrosis organoid biobank[J]. Cell Stem Cell, 2020, 26(4):503-510.e7. doi:10.1016/j.stem.2020.01.019.
[23]	DENG W L, GAO M L, LEI X L, et al. Gene correction reverses ciliopathy and photoreceptor loss in iPSC-derived retinal organoids from retinitis pigmentosa patients[J]. Stem Cell Reports, 2018, 10(4):1267-1281. doi:10.1016/j.stemcr.2018.02.003.
[24]	ZHAO D, LEI W, HU S. Cardiac organoid - a promising perspective of preclinical model[J]. Stem Cell Res Ther, 2021, 12(1):272. doi:10.1186/s13287-021-02340-7.
[25]	GAUDELLI N M, KOMOR A C, REES H A, et al. Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage[J]. Nature, 2017, 551(7681):464-471. doi:10.1038/nature24644.
[26]	AMARACHINTHA S P, MOURYA R, AYABE H, et al. Biliary organoids uncover delayed epithelial development and barrier function in biliary atresia[J]. Hepatology, 2022, 75(1):89-103. doi:10.1002/hep.32107.
[27]	KAJI I, ROLAND J T, RATHAN-KUMAR S, et al. Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance[J]. JCI Insight, 2021, 6(16):e150416. doi:10.1172/jci.insight.150416.
[28]	GOMEZ-MARIANO G, MATAMALA N, MARTINEZ S, et al. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease[J]. Hepatol Int, 2020, 14(1):127-137. doi:10.1007/s12072-019-10007-y.
[29]	RAMALHO A S, FÜRSTOVÁ E, VONK A M, et al. Correction of CFTR function in intestinal organoids to guide treatment of cystic fibrosis[J]. Eur Respir J, 2021, 57(1):1902426[pii]. doi:10.1183/13993003.02426-2019.
[30]	CONTI J, SORIO C, MELOTTI P. Organoid technology and its role for theratyping applications in cystic fibrosis[J]. Children(Basel), 2022, 10(1):4. doi:10.3390/children10010004.
[31]	ROSSI G, MANFRIN A, LUTOLF M P. Progress and potential in organoid research[J]. Nat Rev Genet, 2018, 19(11):671-687. doi:10.1038/s41576-018-0051-9.
[32]	HIRATSUKA K, MIYOSHI T, KROLL K T, et al. Organoid-on-a-chip model of human ARPKD reveals mechanosensing pathomechanisms for drug discovery[J]. Sci Adv, 2022, 8(38):eabq0866. doi:10.1126/sciadv.abq0866.
[33]	LI S R, GULIEVA R E, HELMS L, et al. Glucose absorption drives cystogenesis in a human organoid-on-chip model of polycystic kidney disease[J]. Nat Commun, 2022, 13(1):7918. doi:10.1038/s41467-022-35537-2.
[34]	GUNTI S, HOKE A, VU K P, et al. Organoid and spheroid tumor models: techniques and applications[J]. Cancers(Basel), 2021, 13(4):874. doi:10.3390/cancers13040874.
[35]	RENNER H, SCHÖLER H R, BRUDER J M. Combining automated organoid workflows with artificial intelligence-based analyses: opportunities to build a new generation of interdisciplinary high-throughput screens for Parkinson's disease and beyond[J]. Mov Disord, 2021, 36(12):2745-2762. doi:10.1002/mds.28775.
[36]	TRAN T, SONG C J, NGUYEN T, et al. A scalable organoid model of human autosomal dominant polycystic kidney disease for disease mechanism and drug discovery[J]. Cell Stem Cell, 2022, 29(7):1083-1101.e7. doi:10.1016/j.stem.2022.06.005.